• XIII MedTech Summit

    Register Now

XIII MedTech Summit

Saturday, 7 December 2019

School of International Biodesign (SiB) welcomes you to the summit of Medtech innovators, policy makers, key industry players, academia and investors to exchange ideas and ignite the Indian MedTech ecosystem.

The summit is a cherished tradition initiated 12 years ago to forge together a then nascent Indian MedTech ecosystem. Every year in the month of December, it brings together a diverse community for crowdsourcing of ideas, insights and inspiration. Its purpose is to foster lively conversations and meaningful partnerships


XIII Annual MedTech Summit, 2019

  • Venue Silver Oak Hall,India Habitat Centre Lodhi Road,
    New Delhi - 110003

  • DateDecember 7, 2019 (Saturday)
  • Time 8:30 - 15:30
  • 08.30 – 09:20 Registration & Tea


    09:20 – 09:25 Welcome
    09:25 – 09:30 Saraswati Vandana
    09:30 – 10:30 12 years of SiB: Alumni Presentations (2008 to 2017)
    A compendium of 8 presentations by alumni entrepreneurs who are taking their SiB inventions into the real world.
    10:30 – 11:00 Innovation Projects
    Innovation Fellows: School of International Biodesign

  • 1. 2019 Fellows (July) Batch
    Ashish Verma, Ashutosh Patra, Dr. Jaskirat Kaur, Praveen Bhagat
  • 2. 2019 Fellows (January) Batch
    Dr. Gaurav Gummaraju, Karan Bhatt, Rakesh Patel, Sugat Ingle, Vaishnavi Iyenger
  • 3. 2018 Fellows
    Asish Mohandas – LATURN: Pressure ulcer prevention device Nirmal Kumar and Yasuyuki Matsuura – CAUTI prevention Device
  • 11:00 – 11:15 International Partners: Introduction and Presentation

    2019 Biodesign Fellows, Hiroshima University

    Yasuyuki Matsuura , Assistant Professor, Division of Biodesign, Hiroshima University & SiB Alum

    Dr. Tomohiko Kisaka , Associate Professor, Cardiology, Hiroshima University and 7. Division Chair, Biodesign, Hiroshima University & SiB Alum
    11:15 – 11:20 MedTech Innovation and Research in Academia
    Prof. Chitra Sarkar , Dean (Research), All India Institute of Medical Sciences, New Delhi
    11:20 – 11:30 Transforming India’s Technology Ecosystem
    Dr. Jitendar Sharma ,MD and CEO, Andhra MedTech Zone, Visakhapatnam
    11:30-11:35 Commercial Launch and Dedication to the nation:
    ‘FlexiOH – Bone Immobilization device’ Invented at SiB
  • 1. Inventor: Dr. Pankaj Chhatrala, Founder, OrthoHeal Private Limited
  • 2. Moderator: Dr. Purnima Sharma, CEO, Biotech Consortium India Limited
  • 11:35 – 11:40 Awarding certificates to graduating Biodesign Fellows by
    Dr. Renu Swarup, Secretary, Department of Biotechnology, Ministry of Science & Technology, GOI
    11:40 – 11:50 Keynote Address : Leading Indian MedTech - Vision and Strategy
    Dr. Renu Swarup ,Secretary, Department of Biotechnology, Ministry of Science & Technology, GOI
    11:50 -12:05 Tea Break


    12:05 – 12:50 Panel Discussion 1: Achieving Impact Through Public Sector
    Moderator: Mr. Swaminathan Kumar, Strategist, NHA Innovation Unit
  • 1. Dr. Ajay Khera, Commissioner, Ministry of Health and Family Welfare
  • 2. Mr. Rajesh Singh, Chief Executive Officer, WISH Foundation
  • 3. Mr. Nitin Sisodia, Founder, Sohum Innovation Labs & SiB Alum
  • 4. Mr. Amit Bhatnagar, Founder, Accuster Technologies

  • 12:50 – 13:25 Fireside Chat: What does it take to create a successful med-tech company?
    Moderator: Mr. Pranav Chopra, Founder, Crimson Healthcare & SiB Alum
  • 1. Dr. Abhshek Sen – Co-Founder, Biosense Technologies
  • 2. Mr. K Chandra Shekhar, Founder, Forus Health
  • 13:25 – 14:10 Brainstorming Session: The road ahead for MedTech and SiB
    Moderator: Mr. Yashdeep Kumar, VP, Global Innovation Programs, Stryker
  • 1. Dr. Alka Sharma, Advisor Department of Biotechnology
  • 2. Dr. P. V. M. Rao, Prof and Head, Department of Design, IIT Delhi
  • 3. Mr. Arpit Agarwal, Principal, Blume Ventures
  • 4. Mr. Gurmit Singh, Founder, CEO, Translumina Therapeutics
  • 14:10 – 14:12 Vote of Thanks
    Dr. Avijit Bansal, Fellowship Director, School of International Biodesign & SiB Alum
    14:12 – 15:30 Lunch
    15:30- 17:00 Music, Conversations, Tea, Snacks


    School of International Biodesign

    Stanford India Biodesign programme started in the year 2007 till 2014. School of International Biodesign (SIB) is built on the success of Stanford India Biodesign Programme. School of International Biodesign (SiB) is an innovation program implemented by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India at All India Institute of Medical Sciences (AIIMS), New Delhi and Indian Institute of Technology Delhi (IITD) in collaboration with QUT Australia and Hiroshima University, Japan. Since the inception of the program, DBT has engaged Biotechnology Consortium of India Limited (BCIL) to manage the techno-legal activities of this Programme.
    The current duration of this Programme is upto December 2020.

    The mandate of this Programme is to train next generation of medical technology innovators in India. The focus is on invention/innovation and early stage development of affordable, accessible and available medical technologies for our population.

    During the last 11 years this interdisciplinary Programme has achieved the following; More than 100 medical technology innovators (Doctors, engineers, designers, entrepreneurs) have been trained in the Biodesign process. This includes idea generation through clinical immersion, need finding, need filtration at AIIMS and prototype development at IIT, with IP generation with the help of
    BCIL towards developing innovative technologies for the country.

    More than 50 prototypes have been developed so far which have been further refined validated
    internationally and tested (both preclinical and clinical trials).

    This has led to the development of over 30 medical devices which has been possible by the efforts of young innovators ie 60 Fellows and over 52 Interns who have been meticulously trained in the Biodesign innovation process by the faculty of AIIMS and IIT-D with the international partners. These devices are built on more than 50 patents (National, International and National phase filing). Fifteen technologies have been transferred and twelve medical technology start-ups have been setup by the Fellows trained under this Programme in sync with the ‘Start-Up’ India Programme.